Quest DiagnosticsDGXEarnings & Financial Report
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
DGX Q1 FY2026 Key Financial Metrics
Revenue
$2.9B
Gross Profit
N/A
Operating Profit
$447.0M
Net Profit
$281.0M
Gross Margin
N/A
Operating Margin
15.4%
Net Margin
9.7%
YoY Growth
9.2%
EPS
$2.24
Quest Diagnostics Q1 FY2026 Financial Summary
Quest Diagnostics reported revenue of $2.9B (up 9.2% YoY) for Q1 FY2026, with a net profit of $281.0M (up 12.0% YoY) (9.7% margin).
Key Financial Metrics
| Total Revenue | $2.9B |
|---|---|
| Net Profit | $281.0M |
| Gross Margin | N/A |
| Operating Margin | 15.4% |
| Report Period | Q1 FY2026 |
Quest Diagnostics Annual Revenue by Year
Quest Diagnostics annual revenue history includes year-by-year totals (for example, 2025 revenue was $11.0B).
Quest Diagnostics Quarterly Revenue & Net Profit History
Quest Diagnostics results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $2.9B | +9.2% | $281.0M | 9.7% |
| Q4 FY2025 | $2.8B | +7.1% | $245.0M | 8.7% |
| Q3 FY2025 | $2.8B | +13.2% | $245.0M | 8.7% |
| Q2 FY2025 | $2.8B | +15.2% | $282.0M | 10.2% |
| Q1 FY2025 | $2.7B | +12.1% | $220.0M | 8.3% |
| Q4 FY2024 | $2.6B | +14.6% | $222.0M | 8.5% |
| Q3 FY2024 | $2.5B | +8.4% | $226.0M | 9.1% |
| Q2 FY2024 | $2.4B | +2.5% | $229.0M | 9.6% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.40B | $2.49B | $2.62B | $2.65B | $2.76B | $2.82B | $2.81B | $2.90B |
| YoY Growth | 2.5% | 8.4% | 14.6% | 12.1% | 15.2% | 13.2% | 7.1% | 9.2% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $13.88B | $16.09B | $16.15B | $15.80B | $15.97B | $16.20B | $16.23B | $16.67B |
| Liabilities | $7.26B | $9.29B | $9.38B | $8.87B | $8.74B | $8.94B | $9.05B | $9.01B |
| Equity | $6.62B | $6.81B | $6.78B | $6.93B | $7.23B | $7.26B | $7.17B | $7.67B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $360.0M | $356.0M | $464.0M | $314.0M | $544.0M | $563.0M | $465.0M | $278.0M |